Topic Listing for EDEN Bioscience

Acceleration Stock Options Access Eden Bioscience Corporation Shareholder Account Online Via
Accounting Accounting Changes Error Corrections
Accounting Impairment Disposal Long-lived Assets Accounting Income Taxes
Accounting Pronouncements Implemented Accounting Stock Compensation
Accounting Stock Issued Employees Accounting Stock-based Compensation
Accounting Stock-based Compensation Transition Disclosure Accounting Uncertainty Income Taxes-an Interpretation Fasb Statement
Accounts Receivable Accounts Receivable Allowance Doubtful
Accrued Liabilities Additional Corporate Governance Information
Advance Notice Procedures Director Nominations Other Business Advertising Costs
Agatha Maza Age Actual Storage Conditions Products Cause Them Degrade
Aggregated Option Exercises Last Year-end Values Albert James
Allowance Doubtful Accounts Amended Restated 2000 Stock Incentive Plan
Amendment Amendments
Amendments Articles Anticipated Operating Losses
Articles Articles Dissolution
Attendance Audit Committee
Audit Committee Pre-approval Policy Authority Committees
Automatic Termination Available Information
Basis Presentation Beneficial Ownership Reporting Compliance
Benefits Board
Board Attendance Board Directors
Board Directors Compensation Board Directors Unanimously Recommends Vote Approval Proposals
Bonus Books Records
Bothell Market Wire 2007 Bradley Powell
Business Dependent Success Home Garden Limited Operating History Business Objective Realizing Potential Value Tax Loss Carryforwards
Business Strategy Bylaws
Calculation Filing Fee Capital Resources
Capital Stock Cash Equivalents
Cause Cautionary Statement Forward-looking Statements
Certain Provisions Charter Documents Washington Law Discourage Change Certain Provisions Charter Documents Washington Law Well Shareholder
Certain Relationships Related Transactions Director Independence Certificates Shares Transfer
Certification Certification Pursuant Usc 1350 Adopted 906 Sarbanes-oxley Act
Change-in-control Agreements Changes Disagreements Accountants Accounting Financial Disclosure
Changes Internal Control Over Financial Reporting Chief Executive Officer Certification
Chief Executive Officer Compensation Chief Financial Officer Certification
Closing Thank Time Good Answering Machine Message Code Ethics
Combined Incentive Nonqualified Stock Option Plan Commitments Contingencies
Committees Board Directors Common Stock
Common Stock Delisted Nasdaq Capital Market Find Difficult Common Stock Options
Common Stock Warrants Comparison Cumulative Total Return
Compensation Committee Compensation Committee Interlocks Insider Participation
Compensation Policies Compensation Program
Competition Confidentiality Disclosure Agreement
Consent Independent Registered Public Accounting Firm Considering Effects Prior Misstatements Current Financial Statements
Consolidated Balance Sheets Continue Incur Significant Operating Losses Negative Cash Flow
Continue Script Continuing Cornell University Relationship
Contracts Loans Checks Deposits Contractual Obligations
Controls Procedures Core Technology Platform
Cost Goods Sold Creation Committees
Critical Accounting Policies Estimates Judgments Cumulative Voting
Current Report Pursuant Securities Exchange Act 1934 Currently Depend Products Based Same New Technology Development
Defined Contribution Plan Delivery Email
Delivery Mail Delivery Private Carrier
Delivery Telegraph Dependent Plant Health Care Manufacture Supply Harpin Proteins
Description Director Independence
Director Nomination Procedures Directors
Directors Executive Officers Corporate Governance Disclosure Controls Procedures
Disclosure Intellectual Property Documents Incorporated Reference
Eden Bioscience Eden Bioscience Adopts Shareholder Rights Plan
Eden Bioscience Announces Shareholders Approval Plan Dissolution Liquidation Eden Bioscience Corporation
Eden Bioscience Corporation Subsidiaries Consolidated Balance Sheets Eden Bioscience Corporation Subsidiaries Consolidated Statements Cash Flows
Eden Bioscience Corporation Subsidiaries Consolidated Statements Operations Eden Bioscience Corporation Subsidiaries Consolidated Statements Shareholders Equity
Eden Bioscience Effects 1-for-3 Reverse Stock Split Eden Bioscience Letterhead
Eden Bioscience Solution Advantages Eden Bioscience Website
Effective Date Effective Time
Employee Employee Stock Purchase Plan
Employees Employment
Employment Agreement Employment Change-in-control Agreements
Employment Contracts Termination Change-in-control Arrangements Employment Period
Entry Material Definitive Agreement Equity Compensation Plan Information
Estimates Used Financial Statement Preparation Exact Name Registrant Specified Charter
Exchange Act 1934 Amendment Exchange Rate Risk
Executive Compensation Executive Officer Directors
Executive Officers Directors Executive Officers Not Directors
Exhibits Exit Disposal Activities
Expenses Experienced Limited Grower Usage Messenger Sts Independent Distributors
Expiration Date Exposed Product Liability Claims Adversely Affect Operations
Facsimile Notice Factors Affect Business Future Operating Results Financial Condition
Fair Value Measurements Financial Information
Financial Instruments Concentrations Credit Risk Financial Results Fluctuate Significantly Cause Stock Price Decline
Financial Statements Exhibits Following Letter Being Mailed Holders Record Eden Bioscience
Foreign Currency Translation Form 10-k
Form 10-q Form 8-k
Form Amendment Amended Restated Bylaws Eden Bioscience Corporation Forward-looking Statements
Gain Property Equipment Gain Sale Harpin Protein Technology
Gain Sale Investment General
Genetically Modified Plants Gilberto Gonzalez
Government Regulation Registration Harp-n-tek Products Performance Field Trials
Harp-n-tek Products Safety Harpin Protein-based Home Garden Products
Harpin Works Health
Hello Proxy Representative Bny Mellon Shareowner Services Calling High Level Competition Market Result Price Reductions Reduced
History Losses Since Inception Expect Continue Incur Not Holders
Home Garden Business Currently Depends Products Based Same Home Garden Business Depends Products Based Same New
Home Garden Business Relatively New Limited Market Awareness However
Important Important Additional Information Filed Sec
Important Information Regarding Forward Looking Statements Important Reminder Vote
Inability Address Strain Resources Caused Growth Result Ineffective Inability Comply Regulations Applicable Facilities Procedures Delay Limit
Inability Develop Adequate Sales Marketing Capabilities Prevent Successfully Inability Obtain Regulatory Approvals Comply Ongoing Changing Requirements
Inability Produce High Quality Products Impair Business Inability Protect Patents Proprietary Rights United States Foreign
Inability Retain Key Employees Other Skilled Managerial Technical Inability Satisfy Conditions California Registration Citrus Limit Prevent
Incentives Income Taxes
Indemnification Independence Board Directors
Independent Auditors Index
Index Form 10-q Industry Overview
Interest Expense Interest Income
International Expansion Subject Risks Associated Operations Adversely Affect Internet Telephone Vote Authorizes Named Proxies Shares Same
Inventory Inventory Messenger Held Distributors Aging Not Meet Quality
Inventory Valuation Inventory Valuation Classification
Irs Challenge Amount Net Operating Loss Carryforwards Irs Challenge Amount Tax Loss Carryforwards
Jon Jacoby Largely Development Stage Subject Risks New Enterprise Commercialization
Lease Termination Loss Leases
Legal Proceedings Limitation
Limitation Director Liability Limited Trading Volume Common Stock Find Difficult Dispose
Limits Ownership Common Stock Adverse Consequence Limit Opportunity Limits Ownership Common Stock Shareholder Rights Plan Adverse
Liquidity Liquidity Capital Resources
Liquidity Financial Condition Materially Impaired Required Pay Severance Loss Facility Subleases
Loss Impairment Equipment Leasehold Improvements Loss Lease Termination
Loss Write-down Inventory Low Dosage Quick Activation Plant Systems
Major Customers Management Spend Invest Net Proceeds Sale Ways Shareholders
Managements Annual Report Internal Control Over Financial Reporting Managements Discussion Analysis Financial Condition Results Operations
Manufacturing Market Home Garden Products Competitive Not Resources Required
Market Information Market Registrants Common Equity Related Shareholder Matters Issuer
Material Modification Rights Security Holders Minutes Meetings
Name Shareholder Supporting Boards Unanimous Recommendation Proposals Yes Negligible Human Dietary Environmental Exposure
Net Cash Investing Activities Net Cash Used Operations
Net Loss Per Share Nominating Corporate Governance Committee
Nominee Election Class Director Terms Expire 2008 Nontoxic Plants
North Creek Parkway North Creek Parkway Bothell 98011-8201
Not Able Become Profitable Unless Identify Acquire Other Not Able Net Operating Loss Carryforwards Because Generate
Not Able Realize Value Otherwise Preserve Utilize Net Not Able Realize Value Tax Loss Carryforwards
Not Able Tax Loss Carryforwards Because Generate Taxable Not Adequately Distinguish Products Genetically Modified Plants Public
Not Applicable Notice Annual Meeting Shareholders Held Tuesday 2005
Notice Termination Now Access Eden Bioscience Corporation Account Online
Number Options Number Term Election Directors
Officers Offices
Ongoing Business Dependent Success Home Garden Limited Operating Ongoing Future Field Trials Unsuccessful Unable Achieve Market
Operating Results Likely Fluctuate Resulting Unpredictable Level Sales Option Expiration Date
Option Grants Last Oral Notice
Organization Business Other Assets
Other Companies Claim Infringe Intellectual Property Proprietary Rights Other Events
Other Information Other Matters
Outbound Calling Guide Outstanding 2005
Overview Part
Part Important Information Regarding Forward Looking Statements Part Other Information
Patents Proprietary Rights Performance Graph
Personal Delivery Plan
Please Join Fellow Shareholders Cast Vote Position Duties
Possible Changes Legislation Negatively Affect Ability Tax Benefits Preemptive Rights
President Chief Financial Officer Certification Principal Accountant Fees Services
Principles Consolidation Prior Terms Extinguished
Proceeds Product Development Efforts Based Innovative Technology Commercially Unproven
Product Safety Product Sales
Product Supply License Agreement Phc Product Supply License Agreement Plant Health Care
Products Prompt Attention Voting Shares Appreciated Eliminate Need Additional
Properties Property Equipment
Proposed Plan Complete Dissolution Liquidation Described Below Proposed Plan Dissolution
Prospective Accounting Pronouncements Quantitative Qualitative Disclosures Market Risk
Quarterly Financial Data Quorum Manner Acting
Rapid Changes Technology Render Current Future Products Develop Rapid Changes Technology Render Current Products Other Develop
Rapid Changes Technology Render Products Unmarketable Obsolete Read Proposals Record Vote
Reaffirmation Obligations Recent Accounting Pronouncements
Recent Events Reclassifications
Record Date Outstanding Shares Quorum Redeploy Assets Continue Incur Significant Operating Losses Negative
Reduce Cease Operations Unable Meet Funding Requirements Registered Office Agent
Registrants Business Operations Related Person Transactions
Removal Report Audit Committee
Report Executive Compensation Committee Report Independent Registered Public Accounting Firm
Research Development Expenses Research Development Programs
Resignation Revenue Recognition
Revenues Reverse Split
Revocability Proxies Rhett Atkins Dba
Richard Pahre Rights Agreement
Risks Related Business Plan Utilize Net Operating Loss Risks Related Business Plan Utilize Tax Loss Carryforwards
Risks Related Common Stock Risks Related Continuing Business Operations
Risks Related Plan Dissolution Roger Ivesdal
Rule 14a-101 Safe Animals
Salary Sale Harpin Protein Technology
Sale Harpin Protein Technology Plant Health Care Sale Harpin Protein Technology Plant Health Care Inc
Sales Allowances Sales Marketing Distribution
Sarbanes-oxley Act 2002 Schedule 14a Rule 14a-101
Seal Seasonality
Securities Authorized Issuance Equity Compensation Plans Securities Registered Pursuant Act
Security Ownership Certain Beneficial Owners Management Related Shareholder Segments
Selling General Administrative Expenses Share-based Payment
Shareholder Communications Board Directors Shareholder Rights Plan
Shareholders Not Approve Plan Dissolution Resources Diminish Completely Shareholders Vote Plan Dissolution Liquidation
Signature Signatures
Simple Application Solicitation Proxies
Special Meetings Shareholders Stock Options
Stock Price Performance Graph Stock-based Compensation
Submission Matters Vote Security Holders Submission Shareholder Proposals Inclusion Proxy Statement
Subsidiaries 2009 Successful Building Greater Market Awareness Increasing Sales
Summary Bonus Plan Bradley Powell Summary Compensation Table
Supplemental Payment Termination
Termination Because Death Total Disability Termination Cause Employee
Termination Material Definitive Agreement Termination Without Cause
Third-party Manufacturers Fail Perform Adequately Unable Meet Demand Traditional Chemical Pesticides
Transition Report Pursuant Securities Exchange Act 1934 Transition Report Pursuant Securities Exchange Act 1934 Period
Try Out Unable Compete Phcs Harpin Protein Technology Business Until
Unable Establish Maintain Successful Relationships Independent Distributors Retailers Unable Retain Existing Personnel Not Able Successfully Manage
Valuation Property Equipment Verbal Voting
Violation Other Agreements Visit Web Http Wwwbnymelloncom Shareowner Isd Technical Assistance
Voting Warranty Liability
Wbca Weis Powells Employment Agreements
William Weyerhaeuser Phd Writing
Yes Continue Script 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki